Literature DB >> 29478839

Poor ovarian response as a predictor for live birth in older women undergoing IVF.

Yoni Cohen1, Samer Tannus2, Nabigah Alzawawi2, Weon-Young Son2, Michael Dahan2, William Buckett2.   

Abstract

Women of advanced age present a major challenge for fertility treatments. This study was designed to assess whether poor ovarian response (POR) according to the Bologna criteria is a significant predictor for live birth in women over 40. The outcomes of subsequent IVF cycles were also studied. The results of 1870 fresh IVF cycles in 1212 women were retrospectively analysed. The live birth per cycle was 3.3 times higher (11.61% versus 3.54%, P < 0.001) in good responders with more than three oocytes collected compared with women with less. Ovarian response defined by oocytes collected, but not by the number of follicles, was independently associated with live birth (odds ratio, 2.0; 95% confidence interval, 1.18 to 3.54; P = 0.009). The occurrence of POR in subsequent IVF cycles was only 55%. No differences in live births were found in persistent POR compared with women with at least one good response. A single episode of POR in a first IVF cycle in older women has a limited predictive value for the outcomes of subsequent cycles. POR in women aged 40-43 years, defined by the number of oocytes retrieved, is a predictor for live birth in IVF.
Copyright © 2018 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Advanced maternal age; Bologna criteria; Live birth rate; Poor response

Mesh:

Year:  2018        PMID: 29478839     DOI: 10.1016/j.rbmo.2018.01.008

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  8 in total

Review 1.  Effects of Growth Hormone Supplementation on Poor Ovarian Responders in Assisted Reproductive Technology: a Systematic Review and Meta-analysis.

Authors:  Fen-Ting Liu; Kai-Lun Hu; Rong Li
Journal:  Reprod Sci       Date:  2020-10-19       Impact factor: 3.060

2.  Efficacy and safety of Dingkun pill for female infertility patients with low prognosis undergoing in vitro fertilization-embryo transfer: study protocol for a multicenter, double-blind, randomized, placebo-controlled trial.

Authors:  Jingyan Song; Ting Ma; Yanlin Liang; Xianling Cao; Zhengao Sun
Journal:  Trials       Date:  2020-06-19       Impact factor: 2.279

Review 3.  Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why.

Authors:  Sandro C Esteves; Matheus Roque; Giuliano M Bedoschi; Alessandro Conforti; Peter Humaidan; Carlo Alviggi
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-17       Impact factor: 5.555

Review 4.  Acupuncture for in vitro fertilization in women with poor ovarian response: a systematic review.

Authors:  Soobin Jang; Kyeong Han Kim; Ji Hee Jun; Sooseong You
Journal:  Integr Med Res       Date:  2020-02-27

Review 5.  Ovarian Stimulation in Assisted Reproductive Technology Cycles for Varied Patient Profiles: An Indian Perspective.

Authors:  Padma Rekha Jirge; Madhuri Milind Patil; Rohit Gutgutia; Jatin Shah; Mridubhashini Govindarajan; Varsha Samson Roy; Nalini Kaul-Mahajan; Faddy I Sharara
Journal:  J Hum Reprod Sci       Date:  2022-06-30

6.  Influence of Maternal Age and Ovarian Reserve on the Decision to Continue or to Cancel IVF Cycles in Patients with One or Two Large Follicles: a Dual Effect.

Authors:  Guy Shrem; Mali Salmon-Divon; Alina M Mahfoudh; Jacques Balayla; Alexander Volodarsky-Perel; Sara Henderson; Atif Zeadna; Weon-Young Son; Naama Steiner; Michael H Dahan
Journal:  Reprod Sci       Date:  2021-06-11       Impact factor: 3.060

7.  POSEIDON classification and the proposed treatment options for groups 1 and 2: time to revisit? A retrospective analysis of 1425 ART cycles.

Authors:  Parimala Chinta; Belavendra Antonisamy; Ann M Mangalaraj; Aleyamma T Kunjummen; Mohan S Kamath
Journal:  Hum Reprod Open       Date:  2021-02-14

8.  The Role of Traditional Chinese Formula Ding-Kun Pill (DKP) in Expected Poor Ovarian Response Women (POSEIDON Group 4) Undergoing In Vitro Fertilization-Embryo Transfer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

Authors:  Jing-Yan Song; Dan-Dan Gao; Xian-Ling Cao; Shan Xiang; Yan-Hua Chen; Yi-Li Teng; Xiu-Fang Li; Hai-Ping Liu; Fu-Xin Wang; Bin Zhang; Li-Hua Xu; Li Zhou; Xiang-Hong Huang; Zhen-Gao Sun
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-17       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.